Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 ATGGF | Healthcare | $0.03 | 0.00 | $109.38M | -8.54 | ― | Moderate Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ATGGF | Actinogen Medical | 0.03 | 0.00 | 16.00% |
Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical has bolstered its cash reserves after receiving a $10.8 million research and development tax incentive rebate from the Australian
Actinogen Medical ( ($AU:ACW) ) has issued an update. Actinogen Medical has reached database lock in its pivotal XanaMIA phase 2b/3 trial of Xanamem in mild to moderate Alzheimer’s disease,
Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited has announced an employee share scheme buy-back of its ordinary fully paid shares listed on the ASX under
Actinogen Medical ( ($AU:ACW) ) just unveiled an announcement. Actinogen Medical has scheduled its Annual General Meeting for 11 a.m. on 30 November 2026 in Sydney, where the re‑election and
Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, has its ordinary fully paid shares quoted under the code ACW, positioning it within
The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical has issued 26,315,700 fully paid ordinary shares at $0.0375 each to Forrest Capital or its nominees, covering
Actinogen Medical ( ($AU:ACW) ) has provided an update. Actinogen Medical has applied to the ASX for quotation of 26,315,700 new ordinary fully paid shares, with an issue date of
The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical has completed the underwriting of options, issuing 26,315,700 shortfall shares to Forrest Capital and its nominees, raising
Actinogen Medical ( ($AU:ACW) ) just unveiled an announcement. Actinogen Medical has completed all patient visits in its pivotal XanaMIA Phase 2b/3 trial of oral Xanamem in mild to moderate
The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical Limited, an ASX-listed biotechnology company, has reported changes to its issued capital following the expiry of certain
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| ATGGF | buy | Reiterated | Sep 3, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| ATGGF | Feb 24, 2027TBA | $109.38M | ― | ― | 1.10 | -8.54 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
